AMERICAN BOARD OF CARDIOVASCULAR PERFUSI (EIN 362850496) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1985

Legal Domicile

Principal Officer

DAVID BOYNE

Phone

4149183008

Tax Period

2023-01-01 to 2023-12-31

AMERICAN BOARD OF CARDIOVASCULAR PERFUSI, founded in 1985, is a small nonprofit that reported $900K in total revenue in fiscal year 2023. The organization ran a surplus of $170K, a strong 19% operating margin.

Mission

QUALITY STANDARDS IN PERFUSION

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $855,908

Investment Income $41,903

Other Revenue $1,996

TOTAL REVENUE $899,807

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $482,561

Other Expenses $729,494

TOTAL EXPENSES $729,494

Year-over-Year Comparison

	2023	2022	Change
Revenue	$899,807	$834,129	+0.1%
Expenses	$729,494	$1,103,468	-0.3%
Net Income	$170,313	$-269,339	-1.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DAVID BOYNE	PRESIDENT	8.00	Officer Director	$0	$0	$0
CAROL ANN ROSENBERG	VICE PRESIDENT	8.00	Officer Director	$0	$0	$0
EMILY SAULITIS COLLINS	SECRETARY	8.00	Officer Director	$0	$0	$0
WILLIAM RILEY	TREASURER	8.00	Officer Director	$0	$0	$0
KIRSTEN KALLIES	DIRECTOR	7.00	Director	$0	$0	$0
TYLER KELTING	DIRECTOR	7.00	Director	$0	$0	$0
SCOTT NOESGES	DIRECTOR	7.00	Director	$0	$0	$0
EMILY THUNSTROM-KAHRING	DIRECTOR	7.00	Director	$0	$0	$0
CALEB VARNER	DIRECTOR	7.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$899,807	$729,494	$1,099,816	$170,313
2022	$834,129	$1,103,468	$959,485	$-269,339
2021	$830,354	$765,119	$1,220,637	$65,235
2020	$799,336	$632,505	$1,163,133	$166,831
2019	$796,644	$738,964	$988,571	$57,680
2018	$772,660	$706,708	$930,891	$65,952

AMERICAN BOARD OF CARDIOVASCULAR PERFUSI